Redsense Medical AB (publ) (NGM: REDS)
Sweden
· Delayed Price · Currency is SEK
7.46
-0.04 (-0.53%)
At close: Jan 28, 2025
Redsense Medical AB Revenue
Redsense Medical AB had revenue of 5.03M SEK in the quarter ending September 30, 2024, a decrease of -5.06%. This brings the company's revenue in the last twelve months to 24.22M, down -7.26% year-over-year. In the year 2023, Redsense Medical AB had annual revenue of 25.52M with 52.32% growth.
Revenue (ttm)
24.22M
Revenue Growth
-7.26%
P/S Ratio
5.08
Revenue / Employee
4.84M
Employees
5
Market Cap
123.01M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 25.52M | 8.76M | 52.32% |
Dec 31, 2022 | 16.75M | 410.00K | 2.51% |
Dec 31, 2021 | 16.34M | -757.98K | -4.43% |
Dec 31, 2020 | 17.10M | 2.87M | 20.19% |
Dec 31, 2019 | 14.23M | 5.53M | 63.51% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 25.44B |
Getinge AB | 33.59B |
Sectra AB | 3.14B |
Camurus AB | 1.69B |
Medicover AB | 22.60B |
Vitrolife AB | 3.56B |
Elekta AB | 17.72B |
Bonesupport Holding AB | 814.46M |